Virtual Reality in Motor Neurone Disease

NCT ID: NCT06256107

Last Updated: 2024-02-13

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 6 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-01-13
• Study Completion Date: 2023-10-31

Brief Summary

Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication. The purpose of this study is to establish if Virtual Reality is useful for people with MND and if it helps improve their well being.

Detailed Description

Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication.

As people become increasingly immobile, they become restricted in their ability to perform activities of daily living, access the outdoors, participate in preferred occupational roles or engage in leisure activities. Consequently, there is a deterioration in their ability to experience well being and have quality of life. There is also a significant carer burden as the carer spends long hours in the day looking after the person. The average disease trajectory lasts between 3-5 years, followed by death. More recently, the use of Virtual Reality (VR) technology is being recognised in the field of health. This technology uses the interactions between an individual and a computer generated environment to stimulate different sensory modalities such as visual and auditory. The technology can be accessed commonly using head mounted goggles or head sets. The entertaining or stimulating effect of VR is useful in redirecting the person's attention away from the distressing experiences, such as pain and anxiety. The purpose of this study is to establish if VR is useful for people with MND and if it helps improve their well being.

Conditions

Motor Neuron Disease

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Intervention

The intervention period will last 4 weeks where participants will be required to use the VR set and document the time of use in a daily diary

Group Type: EXPERIMENTAL

Virtual Reality Headset

Intervention Type: DEVICE

Virtual Reality Headset

Interventions

Virtual Reality Headset

Virtual Reality Headset

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Diagnosis of MND

2. Sufficient cognitive ability to understand instructions with regards using the VR kit (ECAS score - minimum 100/136)

3. Has sufficient motor ability/dexterity to use the kit or a carer who will be able to assist with the use of the kit.

4. Can tolerate light and have sufficient head control to wear the head set.

5. English speaking

Exclusion Criteria

1. Poor cognition - inability to understand instructions regarding the use of VR (Total ECAS Score <100/136)

2. Unable to tolerate light/unable to wear the head set

3. Light sensitive epilepsy, severe vertigo or dizziness.

4. Non English speaking

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Lancashire Teaching Hospitals NHS Foundation Trust

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Malabika Ghosh, PhD

Role: PRINCIPAL_INVESTIGATOR

Lancashire Teaching Hospitals NHS Foundation Trust

Locations

Lancashire Teaching Hospitals NHS Foundation Trust

Preston, , United Kingdom

Countries

United Kingdom

Provided Documents

Document Type: Study Protocol

View Document

Other Identifiers

274505

Identifier Type: -

Identifier Source: org_study_id